Variable effects of different corticosteroids on plasma lipids, apolipoproteins, and hepatic apolipoprotein mRNA levels in rats

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 11, Issue 3, 1991, Pages 760-769

  Staels, Bart ^a   Van Toi, Arie ^b   Chan, Lawrence ^c   Verhoeven, Guido ^a,d   Auwerx, Johan ^a,e  

^a Lab V Experimentele Geneesk en E ^*  (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

^e Onderwijs en Navorsing   (Belgium)

Author keywords

Atherosclerosis; Gene regulation; Hyperlipidemia; Steroid hormones

Indexed keywords

APOLIPOPROTEIN; CHOLESTEROL; CORTICOSTEROID; DEXAMETHASONE; HYDROCORTISONE; MESSENGER RNA; TRIAMCINOLONE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; LIVER; NONHUMAN; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

ADRENAL CORTEX HORMONES; ANIMAL; APOLIPOPROTEIN A-I; APOLIPOPROTEIN A-II; APOLIPOPROTEINS; APOLIPOPROTEINS A; APOLIPOPROTEINS B; APOLIPOPROTEINS E; CHOLESTEROL; HYDROCORTISONE; KINETICS; LIPIDS; LIVER; MALE; RATS; RATS, INBRED STRAINS; RECEPTORS, LDL; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; TRIGLYCERIDES;

EID: 0025911660     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.11.3.760     Document Type: Article

References (15)

1. Green S, Chambon P: A superfamily of potentially oncogenic hormone receptors. Nature 1986;324:615-617
2. Evans RM: The steroid and thyroid hormone receptor superfamily. Science 1988;240:889-895
3. Elshourbagy NA, Boguski MS, Liao WSL, Jefferson LS, Gordon JI, Taylor JM: Expression of rat apolipoprotein A-IV and A-I genes: mRNA induction during development and in response to glucocorticoids and insulin. Proc Natl Acad Sci U S A 1985;82:8242-8246
4. Staels B, van Toi A, Verhoeven G, Auwerx J: Apolipoprotein A-IV mRNA abundance is regulated in a tissue-specific manner. Endocrinology 1990;126:2153-2163
5. Nashel DJ: Is atherosclerosis a complication of long-term corticosteroid treatment? Am J Med 1986;80:925-929
6. Ettinger WH Jr, Hazzard WR: Prednisone increases very low density lipoprotein and high density lipoprotein in healthy men. Metabolism 1988;37:1055-1058
7. Ettinger WH Jr, Hazzard WR: Elevated apolipoprotein-B levels in corticosteroid-treated patients with systemic lupus erythematosus. J Clin Endocrinol Metab 1988;67:425-428
8. Taskinen M-R, Kuusi T, Yki-Järvinen H, Nikkilä EA: Shortterm effects of prednisone on serum lipids and high density lipoprotein subfractions in normolipidemic healthy men. J Clin Endocrinol Metab 1988;67:291-299
9. Ettinger WH, Klinefelter HF, Kwiterovich PO: Effect of short-term, low-dose corticosteroids on plasma lipoprotein lipids. Atherosclerosis 1987;63:167-172
10. Zimmerman J, Fainaru M, Eisenberg S: The effects of prednisone therapy on plasma lipoproteins and apolipoproteins: A prospective study. Metabolism 1984;33:521-526
11. Ettinger WH, Goldberg AP, Applebaum-Bowden D, Hazzard WR: Dyslipoproteinemia in systemic lupus erythematosus: Effect of corticosteroids. Am J Med 1987;83:503-508
12. Mitamura T: Glucocorticoid-induced elevation of serum high-density lipoprotein-cholesterol and its reversal by adrenocorticotrophin in the rat. Biochim Biophys Acta 1987;917:121-130
13. Krausz Y, Bar-On H, Shafrir E: Origin and pattern of glucocorticoid-induced hyperlipidemia in rats: Dose-dependent bimodal changes in serum lipids and lipoproteins in relation to hepatic lipogenesis and tissue lipoprotein lipase activity. Biochim Biophys Acta 1981;663:69-82
14. Bagdade JD, Yee E, Albers J, Pykalisto OJ: Glucocorticoids and triglyceride transport: Effects on triglyceride secretion rates, lipoprotein lipase, and plasma lipoproteins in the rat. Metabolism 1976;25:533-542
15. Stern MP, Kolterman OG, Fries JF, McDevitt HO, Reaven GM: Adrenocortical steroid treatment of rheumatic diseases: Effects on lipid metabolism. Arch Intern Med 1973;132:97-101